Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:21466220rdf:typepubmed:Citationlld:pubmed
pubmed-article:21466220lifeskim:mentionsumls-concept:C0029347lld:lifeskim
pubmed-article:21466220lifeskim:mentionsumls-concept:C0022009lld:lifeskim
pubmed-article:21466220lifeskim:mentionsumls-concept:C0456389lld:lifeskim
pubmed-article:21466220lifeskim:mentionsumls-concept:C0243077lld:lifeskim
pubmed-article:21466220lifeskim:mentionsumls-concept:C1705542lld:lifeskim
pubmed-article:21466220lifeskim:mentionsumls-concept:C2349209lld:lifeskim
pubmed-article:21466220lifeskim:mentionsumls-concept:C1549649lld:lifeskim
pubmed-article:21466220pubmed:issue8lld:pubmed
pubmed-article:21466220pubmed:dateCreated2011-4-21lld:pubmed
pubmed-article:21466220pubmed:abstractTextAmantadine inhibits the M2 proton channel of influenza A virus, yet its clinical use has been limited by the rapid emergence of amantadine-resistant virus strains. We have synthesized and characterized a series of polycyclic compounds designed as ring-contracted or ring-expanded analogues of amantadine. Inhibition of the wild-type (wt) M2 channel and the A/M2-S31N and A/M2-V27A mutant ion channels were measured in Xenopus oocytes using two-electrode voltage clamp (TEV) assays. Several bisnoradamantane and noradamantane derivatives inhibited the wt ion channel. The compounds bind to a primary site delineated by Val27, Ala30, and Ser31, though ring expansion restricts the positioning in the binding site. Only the smallest analogue 8 was found to inhibit the S31N mutant ion channel. The structure-activity relationship obtained by TEV assay was confirmed by plaque reduction assays with A/H3N2 influenza virus carrying wt M2 protein.lld:pubmed
pubmed-article:21466220pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21466220pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21466220pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21466220pubmed:languageenglld:pubmed
pubmed-article:21466220pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21466220pubmed:citationSubsetIMlld:pubmed
pubmed-article:21466220pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21466220pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21466220pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21466220pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21466220pubmed:statusMEDLINElld:pubmed
pubmed-article:21466220pubmed:monthAprlld:pubmed
pubmed-article:21466220pubmed:issn1520-4804lld:pubmed
pubmed-article:21466220pubmed:authorpubmed-author:PintoLawrence...lld:pubmed
pubmed-article:21466220pubmed:authorpubmed-author:LambRobert...lld:pubmed
pubmed-article:21466220pubmed:authorpubmed-author:WangJunJlld:pubmed
pubmed-article:21466220pubmed:authorpubmed-author:NaesensLieveLlld:pubmed
pubmed-article:21466220pubmed:authorpubmed-author:DeGradoWillia...lld:pubmed
pubmed-article:21466220pubmed:authorpubmed-author:LuqueF...lld:pubmed
pubmed-article:21466220pubmed:authorpubmed-author:VázquezSantia...lld:pubmed
pubmed-article:21466220pubmed:authorpubmed-author:CampsPelayoPlld:pubmed
pubmed-article:21466220pubmed:authorpubmed-author:MaChunlongClld:pubmed
pubmed-article:21466220pubmed:authorpubmed-author:DuqueMaría...lld:pubmed
pubmed-article:21466220pubmed:authorpubmed-author:TorresEvaElld:pubmed
pubmed-article:21466220pubmed:authorpubmed-author:Juárez-Jiméne...lld:pubmed
pubmed-article:21466220pubmed:issnTypeElectroniclld:pubmed
pubmed-article:21466220pubmed:day28lld:pubmed
pubmed-article:21466220pubmed:volume54lld:pubmed
pubmed-article:21466220pubmed:ownerNLMlld:pubmed
pubmed-article:21466220pubmed:authorsCompleteYlld:pubmed
pubmed-article:21466220pubmed:pagination2646-57lld:pubmed
pubmed-article:21466220pubmed:dateRevised2011-11-17lld:pubmed
pubmed-article:21466220pubmed:meshHeadingpubmed-meshheading:21466220...lld:pubmed
pubmed-article:21466220pubmed:meshHeadingpubmed-meshheading:21466220...lld:pubmed
pubmed-article:21466220pubmed:meshHeadingpubmed-meshheading:21466220...lld:pubmed
pubmed-article:21466220pubmed:meshHeadingpubmed-meshheading:21466220...lld:pubmed
pubmed-article:21466220pubmed:meshHeadingpubmed-meshheading:21466220...lld:pubmed
pubmed-article:21466220pubmed:meshHeadingpubmed-meshheading:21466220...lld:pubmed
pubmed-article:21466220pubmed:meshHeadingpubmed-meshheading:21466220...lld:pubmed
pubmed-article:21466220pubmed:meshHeadingpubmed-meshheading:21466220...lld:pubmed
pubmed-article:21466220pubmed:meshHeadingpubmed-meshheading:21466220...lld:pubmed
pubmed-article:21466220pubmed:meshHeadingpubmed-meshheading:21466220...lld:pubmed
pubmed-article:21466220pubmed:meshHeadingpubmed-meshheading:21466220...lld:pubmed
pubmed-article:21466220pubmed:meshHeadingpubmed-meshheading:21466220...lld:pubmed
pubmed-article:21466220pubmed:meshHeadingpubmed-meshheading:21466220...lld:pubmed
pubmed-article:21466220pubmed:meshHeadingpubmed-meshheading:21466220...lld:pubmed
pubmed-article:21466220pubmed:year2011lld:pubmed
pubmed-article:21466220pubmed:articleTitleExploring the size limit of templates for inhibitors of the M2 ion channel of influenza A virus.lld:pubmed
pubmed-article:21466220pubmed:affiliationLaboratori de Qui?mica Farmace?utica (Unitat Associada al CSIC), Facultat de Farma?cia, and Institute of Biomedicine (IBUB), Universitat de Barcelona, Barcelona, Spain.lld:pubmed
pubmed-article:21466220pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:21466220pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
pubmed-article:21466220pubmed:publicationTypeResearch Support, N.I.H., Extramurallld:pubmed
http://linkedlifedata.com/r...http://linkedlifedata.com/r...pubmed-article:21466220lld:chembl